Shares of Select Medical Holdings Co. (NYSE:SEM) have been assigned a consensus recommendation of “Hold” from the eight brokerages that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $20.80.

A number of analysts recently weighed in on the stock. Credit Suisse Group increased their price target on shares of Select Medical from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Monday, November 5th. ValuEngine upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, November 2nd. Finally, Zacks Investment Research upgraded shares of Select Medical from a “sell” rating to a “hold” rating in a research note on Thursday, October 4th.

Shares of Select Medical stock traded up $0.06 during trading hours on Thursday, hitting $18.59. The company had a trading volume of 456,900 shares, compared to its average volume of 614,266. Select Medical has a twelve month low of $15.83 and a twelve month high of $21.65. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 3.72. The stock has a market cap of $2.51 billion, a price-to-earnings ratio of 19.16, a PEG ratio of 1.26 and a beta of 1.43.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, November 1st. The health services provider reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.05. The business had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.28 billion. Select Medical had a net margin of 4.32% and a return on equity of 15.95%. The company’s revenue for the quarter was up 17.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.14 EPS. On average, analysts forecast that Select Medical will post 1.05 earnings per share for the current fiscal year.

In other Select Medical news, Director James S. Ely III sold 9,000 shares of the company’s stock in a transaction on Tuesday, November 6th. The shares were sold at an average price of $20.00, for a total transaction of $180,000.00. Following the completion of the transaction, the director now owns 101,865 shares in the company, valued at approximately $2,037,300. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Chairman Robert A. Ortenzio sold 37,468 shares of the company’s stock in a transaction on Tuesday, November 6th. The stock was sold at an average price of $20.05, for a total transaction of $751,233.40. Following the transaction, the chairman now owns 7,251,571 shares of the company’s stock, valued at approximately $145,393,998.55. The disclosure for this sale can be found here. In the last quarter, insiders have sold 145,044 shares of company stock valued at $2,907,682. 19.86% of the stock is owned by company insiders.

Institutional investors have recently made changes to their positions in the business. Itau Unibanco Holding S.A. purchased a new position in Select Medical during the 2nd quarter worth $120,000. Cornerstone Wealth Management LLC purchased a new position in Select Medical during the 2nd quarter worth $400,000. UBS Group AG raised its position in Select Medical by 2,189.3% during the 1st quarter. UBS Group AG now owns 7,738 shares of the health services provider’s stock worth $133,000 after buying an additional 7,400 shares during the last quarter. Legacy Financial Advisors Inc. purchased a new position in Select Medical during the 3rd quarter worth $142,000. Finally, Public Employees Retirement Association of Colorado raised its position in Select Medical by 232.4% during the 3rd quarter. Public Employees Retirement Association of Colorado now owns 11,155 shares of the health services provider’s stock worth $205,000 after buying an additional 7,799 shares during the last quarter. Institutional investors own 75.45% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.

See Also: What is a Tariff?

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.